Skip to main content

Table 2 The SF-6D health utility scores (0-100) of Japanese patients with CH-C before, during and after treatment

From: Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials

  LDV/SOF LDV/SOF + RBV SOF + RBV p
Baseline 76.4 ± 12.4 75.9 ± 10.3 76.1 ± 11.8 0.87
Treatment week 4 78.3 ± 12.1 75.5 ± 12.4 76.2 ± 13.0 0.10
Treatment week 8 78.8 ± 12.6* 74.4 ± 11.4 75.5 ± 13.6 0.0023
Treatment week 12 79.2 ± 12.8* 74.3 ± 12.5* 75.7 ± 13.1 0.0012
Post-treatment week 4 78.4 ± 13.1* 76.1 ± 13.3 77.4 ± 13.5 0.28
Post-treatment week 12 78.6 ± 13.0* 76.7 ± 12.3 77.1 ± 14.0 0.36
  1. *p < 0.05 when compared to the baseline level